89 related articles for article (PubMed ID: 6602239)
1. Serial circulating immune complex levels and mitogen responses during progressive tumor growth in WF rats.
Rodrick ML; Steele G; Ross DS; Lahey SJ; Deasy JM; Rayner AA; Harte PJ; Wilson RE; Munroe AE; King VP
J Natl Cancer Inst; 1983 Jun; 70(6):1113-8. PubMed ID: 6602239
[TBL] [Abstract][Full Text] [Related]
2. Effects of specific active immunization on tumor recurrence following primary tumor resection in WF rats with 1,2-dimethylhydrazine-induced bowel cancer.
Ross DS; Steele G; Madara J; Lahey SJ; Ravikumar TS; Wilson RE; Munroe AE; Wright D; King VP
J Natl Cancer Inst; 1984 Sep; 73(3):731-5. PubMed ID: 6590917
[TBL] [Abstract][Full Text] [Related]
3. Consistent fluctuations in quantities of circulating immune complexes during progressive and regressive phases of tumor growth.
Jennette JC
Am J Pathol; 1980 Aug; 100(2):403-10. PubMed ID: 7406017
[TBL] [Abstract][Full Text] [Related]
4. Sequential quantitation of circulating immune complexes in syngeneic and allogeneic rats bearing Moloney sarcomas.
Jennette JC; Feldman JD
J Immunol; 1977 Jun; 118(6):2269-74. PubMed ID: 301157
[TBL] [Abstract][Full Text] [Related]
5. Tumor-induced changes in T cell mitogen responses in rats: suppression of spleen and blood lymphocyte responses and enhancement of thymocyte responses.
Kruisbeek AM; Zijlstra J; Zurcher C
Eur J Immunol; 1978 Mar; 8(3):200-6. PubMed ID: 306926
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppression associated with SJL/J murine lymphoma. I. Suppression of cell-mediated immune responses after tumor transplantation.
Kumar RK; Lykke AW; Penny R
J Natl Cancer Inst; 1981 Dec; 67(6):1269-75. PubMed ID: 6458725
[TBL] [Abstract][Full Text] [Related]
7. Occurrence of two distinct subpopulations of suppressor cells in rats bearing chemically induced tumors.
Iguchi S; Ishii Y; Yamaoka H; Sato N; Kikuchi K
Neoplasma; 1981; 28(1):51-8. PubMed ID: 6456424
[TBL] [Abstract][Full Text] [Related]
8. [Circulating immune complex (CIC) and antitumor antibody in the serum of rats with thyroid carcinoma induced by 132I].
Hou JC
Zhonghua Zhong Liu Za Zhi; 1986 May; 8(3):173-5. PubMed ID: 3743342
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of two antigen nonspecific assays for circulating immune complexes using a model system.
Rodrick M; Rayner A; Steele G; Harte P; Finn D; Verhave M; Munroe A; Zamcheck N; Wilson R
J Clin Lab Immunol; 1982 Apr; 7(3):193-8. PubMed ID: 6178827
[TBL] [Abstract][Full Text] [Related]
10. Effects of tumor growth on interleukins and circulating immune complexes. Mechanisms of immune unresponsiveness.
Ravikumar T; Steele G; Rodrick M; Ross D; Wilson R; Lahey S; Wright D; Munroe A; King V
Cancer; 1984 Mar; 53(6):1373-8. PubMed ID: 6607100
[TBL] [Abstract][Full Text] [Related]
11. [The lack of generalized immunosuppression in C57BL/6 mice during progressive growth of syngenic T lymphoma EL-4 and Lewis lung carcinoma 3LL].
Fuks BB; Malaĭtsev VV; Bogdanova IM
Biull Eksp Biol Med; 1986 Jun; 101(6):725-8. PubMed ID: 3089345
[TBL] [Abstract][Full Text] [Related]
12. Comparison of antibody isotypes in sera and circulating immune complexes during tumor growth and metastasis of three tumor models in mice.
McDonald TL; Collins M; Talmadge JE
Cancer Res; 1984 Nov; 44(11):4933-7. PubMed ID: 6435859
[TBL] [Abstract][Full Text] [Related]
13. Adenocarcinoma R-3327 of the Copenhagen rat as a suitable model for immunological studies of prostate cancer.
Lopez DM; Voigt W
Cancer Res; 1977 Jul; 37(7 Pt 1):2057-61. PubMed ID: 301055
[TBL] [Abstract][Full Text] [Related]
14. Regulatory action of THF on T-cell reactivity to mitogens.
Gabizon A; Trainin N
Thymus; 1980 Jan; 1(4-5):225-39. PubMed ID: 6969474
[TBL] [Abstract][Full Text] [Related]
15. Distribution of normal T lymphocytes in tumor-bearing rats.
Klobusická M; Koníková E
Neoplasma; 1982; 29(6):727-34. PubMed ID: 6984490
[TBL] [Abstract][Full Text] [Related]
16. Effect of tumor growth on migratory properties of T lymphocytes in rats.
Klobusická M; Koníková E; Novotná L
Neoplasma; 1980; 27(6):675-82. PubMed ID: 6973097
[TBL] [Abstract][Full Text] [Related]
17. [Humoral and cellular factors of immunity in mice with hepatoma 22A].
Kiseleva EP; Kositskaia LS; Ogurtsov RP
Vopr Onkol; 1988; 34(5):587-92. PubMed ID: 3289261
[TBL] [Abstract][Full Text] [Related]
18. Effect of blood transfusions on immune function. Part VI. Effect on immunologic response to tumor.
Waymack JP; Fernandes G; Yurt RW; Venkatraman JT; Burleson DG; Guzman RF; Mason AD; Pruitt BA
Surgery; 1990 Aug; 108(2):172-7; discussion 177-8. PubMed ID: 2382219
[TBL] [Abstract][Full Text] [Related]
19. Quantification of polyethylene glycol precipitable circulating immune complex from carcinoma of cervix patients.
Das S
Arch Geschwulstforsch; 1987; 57(4):283-6. PubMed ID: 3675140
[TBL] [Abstract][Full Text] [Related]
20. The Eker renal tumor rat. General immune status in relation to a varying tumor burden.
Waynforth HB; Roe GM
Neoplasma; 1981; 28(6):697-703. PubMed ID: 7040995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
